Robert Hershberg
Directeur/Membre du Conseil chez Eleusis Holdings Ltd.
Postes actifs de Robert Hershberg
Sociétés | Poste | Début | Fin |
---|---|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Private Equity Investor | 01/01/2020 | - |
Eleusis Holdings Ltd.
Eleusis Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Beckley Psytech Ltd., Eleusis Holdings Ltd. is a life science company based in London, UK. The British company is leading translational research in bold new directions and developing a broad and differentiated portfolio of drug candidates to address unmet needs within and beyond psychiatry. Eleusis is dedicated to transforming psychedelics into medicines, empowering patients, and facilitating access to care. The company was founded in 2017. The CEO is Shlomi Raz. Eleusis Holdings was acquired by Beckley Psytech Ltd. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Robert Hershberg
Statistiques
Internationale
Etats-Unis | 2 |
Royaume-Uni | 2 |
Opérationnelle
Private Equity Investor | 1 |
Director/Board Member | 1 |
Sectorielle
Finance | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Finance |
Eleusis Holdings Ltd.
Eleusis Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Beckley Psytech Ltd., Eleusis Holdings Ltd. is a life science company based in London, UK. The British company is leading translational research in bold new directions and developing a broad and differentiated portfolio of drug candidates to address unmet needs within and beyond psychiatry. Eleusis is dedicated to transforming psychedelics into medicines, empowering patients, and facilitating access to care. The company was founded in 2017. The CEO is Shlomi Raz. Eleusis Holdings was acquired by Beckley Psytech Ltd. | Commercial Services |
- Bourse
- Insiders
- Robert Hershberg
- Expérience